GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 24 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $480,000 | -21.4% | 145,865 | +8.5% | 0.02% | -23.1% |
| Q2 2020 | $611,000 | +141.5% | 134,429 | +78.3% | 0.03% | +100.0% |
| Q1 2020 | $253,000 | +141.0% | 75,383 | +312.9% | 0.01% | +225.0% |
| Q4 2019 | $105,000 | -8.7% | 18,255 | -27.8% | 0.00% | -20.0% |
| Q3 2019 | $115,000 | – | 25,274 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,347,755 | $574,818 | 0.02% |
| Virtu Financial LLC | 31,633 | $13 | 0.00% |
| Western Wealth Management, LLC | 29,537 | $12,597 | 0.00% |
| Belpointe Asset Management LLC | 14,050 | $5,992 | 0.00% |
| TSFG, LLC | 3,000 | $1 | 0.00% |
| ZRC WEALTH MANAGEMENT, LLC | 100 | $43 | 0.00% |
| Allworth Financial LP | 250 | $107 | 0.00% |
| JANE STREET GROUP, LLC | 13,189 | $5,625 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 138,040 | $58,874 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 500 | $214 | 0.00% |